Your trusted source for investing success

Tag: biotechnology company

Valens Groworks Closes Second Tranche of Offering

Valens Groworks Closes Second Tranche of Offering

Valens GroWorks Corp. (CSE:VGW) (the “Company” or “Valens”), a biotechnology company specializing in the production, research, development and commercialization of novel, cannabinoid-based products and drug therapies, is pleased to announce the closing of a further 505,200 units (the “Units”) for proceeds of $505,200, the second tranche of its non-brokered private

Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

Valens GroWorks Added to CSE25 Index

Valens GroWorks Added to CSE25 Index

Valens GroWorks Corp. (CSE:VGW) (the “Company” or “Valens”), a biotechnology company specializing in the production, research, development and commercialization of novel, cannabinoid-based products and drug therapies, is pleased to announce its inclusion in the CSE25 Index.

Valens GroWorks Signs “MOU” With Okanagan Interventional Pain Clinic

Valens GroWorks Signs “MOU” With Okanagan Interventional Pain Clinic

Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), is pleased to announce the signing of a Memorandum of Understanding (“MOU”) with the Bill Nelems Pain and Research Centre, operating the Okanagan Interventional Pain Clinic, to form a strategic alliance for the purpose of conducting clinical research and development of

Valens Groworks arranges $500,000 private placement

Valens Groworks arranges $500,000 private placement

Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licenced, vertically integrated provider of cannabis products, is pleased to announce a follow up non-brokered private placement of up to 500,000 units (the “Units”) at a price of $1.00 per Unit for gross proceeds of up to $500,000 (the “Offering”).

Valens Groworks Signs Craftgrow Deal With Canopy Growth

Valens Groworks Signs Craftgrow Deal With Canopy Growth

Valens GroWorks Corp. (CSE:VGW) (“Valens GroWorks”, or the “Company”) is pleased to announce that its wholly owned subsidiary Valens Agritech Ltd. (“Valens”), a Health Canada Licensed Dealer, has signed a supply and sales agreement with Canopy Growth Corporation (TSX: WEED) (“Canopy Growth”) for the distribution, marketing and sale of the

Valens Groworks Closes Final Tranche Of Offering

Valens Groworks Closes Final Tranche Of Offering

Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“), a vertically integrated provider of cannabis products, is pleased to announce the closing of an additional 85,000 units (the “Units”) for proceeds of $85,000, the final tranche of its non-brokered $1.00 per Unit private placement (the “Offering”) first announced on July 26, 2017. The Offering

5 Top Biotech Stocks on the TSX Year-to-date

5 Top Biotech Stocks on the TSX Year-to-date

The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top NASDAQ Biotech Stocks: Viking Therapeutics Leads the Week

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/5-top-nasdaq-biotech-stocks-viking-therapeutics-leads-week/